NeueHealth Inc (NEUE) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): N/A
• Revenue Growth: -13.83%
• EPS Growth: 87.09%
• Country: US
• Employees: N/A
• Sector: N/A
• Sector Strength: N/A
• Industry: N/A
• EPS (TTM): N/A
• Shares Outstanding: N/A
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 49 Neutral
• Price Target: $6.50

The overall stock score of 49 reflects significant financial challenges, with negative profitability and a weak balance sheet being the most impactful factors. Despite positive sentiment from the earnings call and strategic growth initiatives, the company's valuation and technical indicators suggest caution.

NeueHealth Inc Business Overview & Revenue Model

Company Description

NeueHealth Inc (NEUE) is a healthcare technology company focused on transforming the way healthcare is delivered and managed. Operating within the digital health and telemedicine sectors, NeueHealth specializes in providing innovative solutions that enhance patient engagement, streamline healthcare operations, and improve overall health outcomes. The company offers a suite of products and services, including a digital health platform for remote patient monitoring, telehealth services, and data analytics tools that support healthcare providers in making informed decisions.

How the Company Makes Money

NeueHealth generates revenue through multiple streams, including subscription fees from healthcare providers for access to its digital health platform, transaction fees from telehealth consultations, and licensing fees for its data analytics tools. Additionally, the company may engage in strategic partnerships with healthcare organizations, insurance companies, and technology firms to expand its service offerings and reach. These collaborations can lead to revenue-sharing agreements, further enhancing its income potential. The increasing demand for telehealth services and digital health solutions, accelerated by the COVID-19 pandemic, has significantly contributed to NeueHealth's growth and revenue generation.

NeueHealth Inc Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

NeueHealth Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: ―
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NEUE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 6.72, equal to the 50-day MA of 6.70, and equal to the 200-day MA of 6.76, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 52.93 is Neutral, neither overbought nor oversold. The STOCH value of 58.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NEUE.

NeueHealth Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	―	―	―	―	―	―	―